AXA Investment Managers’s Bristol-Myers Squibb BMY Stock Holding History

AXA Investment Managers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$141M	Buy	+3,125,540	New	+$146M	0.38%	50

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AXA Investment Managers's BMY Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 3,125,540 shares worth $141M. The stake represents 0.38% of the portfolio and ranks #50 among its holdings.

2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

AXA Investment Managers held 3,125,540 shares of Bristol-Myers Squibb worth $141M as of Q3 2025.
Bristol-Myers Squibb was a new AXA Investment Managers position in Q3 2025.
Bristol-Myers Squibb made up 0.38% of AXA Investment Managers's portfolio in Q3 2025, its #50 holding.
2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.